Biorelate Company
Biorelate provides biomedical research services. It engages in the research of biomarkers for the diagnosis of prostate cancer; target validation; and new drug development services. Daniel Jamison founded Biorelate in 2014. It has its headquarters in Oldham in the United Kingdom.
Investors
.png)
.png)
(Reupload).png)
Technology:
Big Data, Biotechnology, Health Care, Life Science, Medical
Industry:
Early Drug Development
Headquarters:
Oldham, Oldham, United Kingdom
Founded Date:
2014-01-01
Employees Number:
11-50
Funding Status:
Grant
Investors Number:
4
Total Funding:
1063423
Estimated Revenue:
$1M to $10M
Last Funding Date:
2018-09-18
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership